4//SEC Filing
Heier Jeffrey S. 4
Accession 0001104659-24-106327
CIK 0001393434other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 5:20 PM ET
Size
7.5 KB
Accession
0001104659-24-106327
Insider Transaction Report
Form 4
Heier Jeffrey S.
Chief Scientific Officer
Transactions
- Award
Common Stock
2024-10-02+100,000→ 272,007 total - Award
Stock Option (Right to Buy)
2024-10-02+200,000→ 200,000 totalExercise: $9.31Exp: 2034-10-01→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]On October 2, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal annual installments, beginning on October 1, 2025.
- [F2]Vests over four years, with 1/48 of the shares vesting monthly beginning on November 1, 2024.
Documents
Issuer
OCULAR THERAPEUTIX, INC
CIK 0001393434
Entity typeother
Related Parties
1- filerCIK 0001653082
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 5:20 PM ET
- Size
- 7.5 KB